. .
Deutsch
Deutschland
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Suchtools
Anmelden

Anmelden mit Facebook:

Registrieren
Passwort vergessen?


Such-Historie
Merkliste
Links zu eurobuch.com

Dieses Buch teilen auf…
..?
Buchtipps
Aktuelles
Tipp von eurobuch.com
FILTER
- 0 Ergebnisse
Kleinster Preis: 0.93 EUR, größter Preis: 140.00 EUR, Mittelwert: 49.59 EUR
Melanoma: Biologically Targeted Therapeutics
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)

Melanoma: Biologically Targeted Therapeutics - gebunden oder broschiert

2002, ISBN: 0896038769, Lieferbar binnen 4-6 Wochen Versandkosten:Versandkostenfrei innerhalb der BRD

ID: 9780896038769

Internationaler Buchtitel. In englischer Sprache. Verlag: SPRINGER VERLAG GMBH, 408 Seiten, L=238mm, B=161mm, H=26mm, Gew.=871gr, [GR: 16960 - HC/Medizin/Andere Fachgebiete], [SW: - Medical / Nursing], Gebunden, Klappentext: Ernest C. Borden, MD, has assembled a multidisciplinary team of established and emerging leaders to detail the clinical problems and factors influencing the therapeutic deployment of these biologicals. The contributors focus on providing the rationale and background for translating the many promising biologically targeted therapies via clinical trials into effective new therapies. Among the interventional agents treated are: cytokines, monoclonal antibodies, targeted inhibitors, cellular therapies, and angiogenesis inhibitors. Special attention is given to adjuvant therapies for melanoma in patients staged as being at high risk for recurrence. These include interferons, vaccines aimed at stimulating T cell response, and therapies targeted at abnormal melanoma cell proliferative signaling and angiogenesis inhibitors. Among the cutting-edge therapies discussed are novel cytokines that influence dendritic NK and T cell function, an allogenic cellular extract vaccine, and new targets (Nf-kB and IL-8) for anti-angiogenesis therapies. Ernest C. Borden, MD, has assembled a multidisciplinary team of established and emerging leaders to detail the clinical problems and factors influencing the therapeutic deployment of these biologicals. The contributors focus on providing the rationale and background for translating the many promising biologically targeted therapies via clinical trials into effective new therapies. Among the interventional agents treated are: cytokines, monoclonal antibodies, targeted inhibitors, cellular therapies, and angiogenesis inhibitors. Special attention is given to adjuvant therapies for melanoma in patients staged as being at high risk for recurrence. These include interferons, vaccines aimed at stimulating T cell response, and therapies targeted at abnormal melanoma cell proliferative signaling and angiogenesis inhibitors. Among the cutting-edge therapies discussed are novel cytokines that influence dendritic NK and T cell function, an allogenic cellular extract vaccine, and new targets (Nf-kB and IL-8) for anti-angiogenesis therapies.

Neues Buch DEU
Buchgeier.com
Lieferbar binnen 4-6 Wochen (Besorgungstitel) Versandkosten:Versandkostenfrei innerhalb der BRD
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Melanoma: Biologically Targeted Therapeutics - Borden, Ernest C.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)

Borden, Ernest C.:

Melanoma: Biologically Targeted Therapeutics - neues Buch

ISBN: 9780896038769

Ernest C. Borden, MD, has assembled a multidisciplinary team of established and emerging leaders to detail the clinical problems and factors influencing the therapeutic deployment of these biologicals. The contributors focus on providing the rationale and background for translating the many promising biologically targeted therapies via clinical trials into effective new therapies. Among the interventional agents treated are: cytokines, monoclonal antibodies, targeted inhibitors, cellular therapies, and angiogenesis inhibitors. Special attention is given to adjuvant therapies for melanoma in patients staged as being at high risk for recurrence. These include interferons, vaccines aimed at stimulating T cell response, and therapies targeted at abnormal melanoma cell proliferative signaling and angiogenesis inhibitors. Among the cutting-edge therapies discussed are novel cytokines that influence dendritic NK and T cell function, an allogenic cellular extract vaccine, and new targets (Nf-kB and IL-8) for anti-angiogenesis therapies. Melanoma: Biologically Targeted Therapeutics Borden, Ernest C. Ernest C. Borden, MD, has assembled a multidisciplinary team of established and emerging leaders to detail the clinical problems and factors influencing the therapeutic deployment of these biologicals. The contributors focus on providing the rationale and background for translating the many promising biologically targeted therapies via clinical trials into effective new therapies. Among the interventional agents treated are: cytokines, monoclonal antibodies, targeted inhibitors, cellular therapies, and angiogenesis inhibitors. Special attention is given to adjuvant therapies for melanoma in patients staged as being at high risk for recurrence. These include interferons, vaccines aimed at stimulating T cell response, and therapies targeted at abnormal melanoma cell proliferative signaling and angiogenesis inhibitors. Among the cutting-edge therapies discussed are novel cytokines that influence dendritic NK and T cell function, an allogenic cellular extract vaccine, and new targets (Nf-kB and IL-8) for anti-angiogenesis therapies.

Neues Buch [USA] Betterworldbooks.com
Versandkosten:zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Melanoma: Biologically Targeted Therapeutics (Current Clinical Oncology) - Ernest C. Borden
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Ernest C. Borden:
Melanoma: Biologically Targeted Therapeutics (Current Clinical Oncology) - gebrauchtes Buch

ISBN: 9780896038769

ID: 682708088

Humana Press. Used - Good. Former Library book. Shows some signs of wear, and may have some markings on the inside. 100% Money Back Guarantee. Shipped to over one million happy customers. Your purchase benefits world literacy!, Humana Press

gebrauchtes bzw. antiquarisches Buch Biblio.com
Better World Books
Versandkosten: EUR 7.38
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

< zum Suchergebnis...
Details zum Buch
Melanoma: Biologically Targeted Therapeutics
Autor:

Borden, Ernest C.

Titel:

Melanoma: Biologically Targeted Therapeutics

ISBN-Nummer:

9780896038769

Ernest C. Borden, MD, has assembled a multidisciplinary team of established and emerging leaders to detail the clinical problems and factors influencing the therapeutic deployment of these biologicals. The contributors focus on providing the rationale and background for translating the many promising biologically targeted therapies via clinical trials into effective new therapies. Among the interventional agents treated are: cytokines, monoclonal antibodies, targeted inhibitors, cellular therapies, and angiogenesis inhibitors. Special attention is given to adjuvant therapies for melanoma in patients staged as being at high risk for recurrence. These include interferons, vaccines aimed at stimulating T cell response, and therapies targeted at abnormal melanoma cell proliferative signaling and angiogenesis inhibitors. Among the cutting-edge therapies discussed are novel cytokines that influence dendritic NK and T cell function, an allogenic cellular extract vaccine, and new targets (Nf-kB and IL-8) for anti-angiogenesis therapies.

Detailangaben zum Buch - Melanoma: Biologically Targeted Therapeutics


EAN (ISBN-13): 9780896038769
ISBN (ISBN-10): 0896038769
Gebundene Ausgabe
Erscheinungsjahr: 2002
Herausgeber: SPRINGER VERLAG GMBH
408 Seiten
Gewicht: 0,871 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 16.04.2007 08:03:51
Buch zuletzt gefunden am 19.04.2015 15:29:06
ISBN/EAN: 9780896038769

ISBN - alternative Schreibweisen:
0-89603-876-9, 978-0-89603-876-9

< zum Suchergebnis...
< zum Archiv...
Benachbarte Bücher